Aligning payer and provider strategies with the latest evidence to optimize clinical outcomes for patients with neuromyelitis optica spectrum disorder
Journal of Managed Care & Specialty Pharmacy | November 25, 2022 | Volume: 28 | Issue: 12-a Suppl | Pages: S3-S27
10.18553/jmcp.2022.28.12-a.s1
| PMID 36427336